$34.11 -0.17 (%) Pfizer Inc - NYSE

May. 26, 2015 | 04:00 PM

Partner Headlines

  1. Amgen's Cholesterol Fighting Drug Receives EU Approval

    GuruFocus | May. 26, 2015 | 16:46PM EST
  2. Big Pharma Companies Are Betting On Regenerative Medicine - Should You?

    GuruFocus | May. 26, 2015 | 13:35PM EST
  3. Analyst Says GlaxoSmithKline Acquisition Will Benefit Pfizer

    GuruFocus | May. 22, 2015 | 18:21PM EST
  4. Benzinga's M&A Chatter for Thursday May 21, 2015

    Benzinga | May. 21, 2015 | 19:08PM EST
  5. The Most Popular Stocks Held By 4 Different Generations Of Investors

    Benzinga | May. 21, 2015 | 07:45AM EST
  6. Stocks: Quiet Open Ahead Of Fed; Dycom Rockets, Airlines Ruffled

    IBD | May. 20, 2015 | 10:42AM EST
  7. Like Big Dividends? 6 Steady Payers You Can Rely On

    IBD | May. 19, 2015 | 18:20PM EST
  8. Which Top Dividend Stocks Get Thumbs Up From Buffett?

    IBD | May. 18, 2015 | 18:15PM EST
  9. Joel Greenblatt Increases Position in Pfizer

    GuruFocus | May. 17, 2015 | 17:10PM EST
  10. U.S. Loves Europe As Pharma, Energy Boost M&A

    IBD | May. 14, 2015 | 17:45PM EST
  11. Making Money With Charles Payne: 05/13/15

    FoxBusiness | May. 13, 2015 | 18:00PM EST
  12. S&P 500 Index Futures Trading Higher

    Benzinga | May. 13, 2015 | 10:43AM EST
  13. Apple, King Of Cash, Also King Of Debt From Buybacks

    IBD | May. 7, 2015 | 13:13PM EST
  14. Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio

    GuruFocus | May. 7, 2015 | 12:24PM EST
  15. Zoetis

    IBD | May. 5, 2015 | 18:49PM EST
  16. Pfizer is a Good Buy Post Recent Results

    GuruFocus | May. 3, 2015 | 22:51PM EST
  17. Biogen Making A Breakthrough In Treating Alzheimer's

    GuruFocus | May. 2, 2015 | 16:04PM EST
  18. Pfizer is Sobi's mystery bidder?

    IBD | Apr. 30, 2015 | 18:42PM EST
  19. Crouching Tigers, Hidden Assets - Smead Capital Management

    GuruFocus | Apr. 30, 2015 | 18:19PM EST
  20. Currency Woes Impact Pfizer Sales In Q1, Management Lowers Future Guidance

    GuruFocus | Apr. 29, 2015 | 14:00PM EST
  21. Big Pharma Beats Wall St.

    IBD | Apr. 28, 2015 | 19:11PM EST
  22. Merck Up On Q1, Januvia Report; Bristol, Pfizer Mixed

    IBD | Apr. 28, 2015 | 12:47PM EST
  23. US Stock Futures Down Ahead Of Earnings

    Benzinga | Apr. 28, 2015 | 07:46AM EST
  24. Pfizer Posts Upbeat Q1 Results, But Lowers FY Forecast

    Benzinga | Apr. 28, 2015 | 07:34AM EST
  25. Keep an Eye on These 10 Stocks for April 28, 2015

    Benzinga | Apr. 28, 2015 | 05:14AM EST
  26. Nasdaq Leads Market Lower As Medical Stocks Tumble

    IBD | Apr. 27, 2015 | 16:16PM EST
  27. 4 Drug Giants Reporting Earnings This Week

    IBD | Apr. 27, 2015 | 13:33PM EST
  28. U.S. Tech, Dollar & Health Care ETFs To Watch This Week

    Benzinga | Apr. 26, 2015 | 10:52AM EST
  29. Nasdaq Takes Lead In Mixed Open; Microsoft Surges, Biogen Dives

    IBD | Apr. 24, 2015 | 10:35AM EST
  30. Beat The Market Twice: 5 Top Dividend Stock Winners

    IBD | Apr. 22, 2015 | 17:24PM EST
  31. Pfizer On The Mission Of Developing Life-Saving Cancer Drugs

    GuruFocus | Apr. 22, 2015 | 13:52PM EST
  32. Pfizer Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia

    Benzinga | Apr. 21, 2015 | 08:05AM EST
  33. Global & Strategic Partners Initiate Phase III Study with Avelumab in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer

    Benzinga | Apr. 20, 2015 | 08:04AM EST
  34. Teva Getting Serious About Mylan Bid, Says Report

    IBD | Apr. 17, 2015 | 15:54PM EST
  35. Can a Strong U.S. Dollar Increase or Decrease the Value of Global Currencies?

    GuruFocus | Apr. 16, 2015 | 17:19PM EST
  36. Are U.S. Investors Showing Confidence in the Stock Market?

    GuruFocus | Apr. 16, 2015 | 16:54PM EST
  37. New drug trial results positive

    IBD | Apr. 15, 2015 | 18:38PM EST
  38. Pfizer, Biogen, AbbVie Get Good Drug-Trial News

    IBD | Apr. 15, 2015 | 11:49AM EST
  39. Benzinga's M&A Chatter for Monday April 13, 2015

    Benzinga | Apr. 13, 2015 | 17:48PM EST
  40. Pfizer's

    IBD | Mar. 3, 2015 | 18:33PM EST
  41. Akorn Stock Goes Nuts As Buyout Strategy Pays Off

    IBD | Feb. 26, 2015 | 17:27PM EST
  42. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  43. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga | Feb. 23, 2015 | 07:34AM EST
  44. Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices

    Benzinga | Feb. 20, 2015 | 13:10PM EST
  45. New Potential HIV Vaccine Drug 'Absolutely 100% Effective' In Monkeys

    Benzinga | Feb. 20, 2015 | 07:22AM EST
  46. Hot Dividend Stocks: Pfizer Pulls Back Into Buy Range

    IBD | Feb. 19, 2015 | 17:32PM EST
  47. Hospira's Q4 Earnings Were Bright, Though Acquisition Is In The Cards

    GuruFocus | Feb. 19, 2015 | 12:06PM EST
  48. Novartis, Verastem & Cepheid Making Biotech Headlines On Friday

    Benzinga | Feb. 13, 2015 | 15:32PM EST
  49. Pfizer Announces FDA Acceptance for Review of NDA for ALO-02

    Benzinga | Feb. 13, 2015 | 10:28AM EST
  50. Fast Money Picks For February 12

    Benzinga | Feb. 12, 2015 | 08:22AM EST
Trading Center